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Clinical PerspectiveWhat Is New?Tricuspid valve surgery shares less than 9% of overall cardiac valve surgery volume in Taiwan.Tricuspid repair demonstrated significantly lower risks of all‐cause mortality, composite outcome, and readmission in both isolated and concomitant surgery compared with replacement.What Are the Clinical Implications?Tricuspid valve repair is a preferred option to replacement whenever feasible.Further prospective clinical trials are warranted for tricuspid repair versus replacement.

 {#jah35024-sec-0008}

Nonstandard Abbreviations and Acronyms*ICD‐9‐CM International Classification of Diseases, Ninth Revision, Clinical Modification*IPTW Inverse probability of treatment weightingNHI National Health InsuranceNHIRD National Health Insurance Research DatabaseTV Tricuspid valve

Introduction {#jah35024-sec-0009}
============

Tricuspid valve (TV) disease is a forgotten entity and is often undertreated because TV surgery, especially isolated TV surgery, is notorious for its high mortality (8%--14%) and morbidity.[1](#jah35024-bib-0001){ref-type="ref"}, [2](#jah35024-bib-0002){ref-type="ref"}, [3](#jah35024-bib-0003){ref-type="ref"}, [4](#jah35024-bib-0004){ref-type="ref"}, [5](#jah35024-bib-0005){ref-type="ref"}, [6](#jah35024-bib-0006){ref-type="ref"}, [7](#jah35024-bib-0007){ref-type="ref"}, [8](#jah35024-bib-0008){ref-type="ref"}, [9](#jah35024-bib-0009){ref-type="ref"} Patients with mild or moderate tricuspid regurgitation (TR) are often treated conservatively with medical therapies. Surgery is considered a more definitive treatment in patients with severe TR. The 2017 European Society of Cardiology/European Association for Cardio‐Thoracic Surgery and 2014 American Heart Association/American College of Cardiology guidelines recommend isolated TV surgery in case of severe primary symptomatic isolated TR without right ventricular dysfunction or mild to moderate symptoms with progressive right ventricular dysfunction. For concomitant TV surgery, the recent guidelines recommend surgery in individuals with mild symptoms with tricuspid annulus dilation or recent signs of right heart failure, in addition to those with severe primary and secondary TR.[10](#jah35024-bib-0010){ref-type="ref"}, [11](#jah35024-bib-0011){ref-type="ref"}

The decision of the type of TV surgery remains controversial. TV repair is in general preferred to a replacement, although some studies have demonstrated no difference in the outcomes between repair and replacement.[12](#jah35024-bib-0012){ref-type="ref"}, [13](#jah35024-bib-0013){ref-type="ref"} TV replacement presents the risks of degeneration with bioprosthetic valves and thrombosis and long‐term anticoagulant use with mechanical valves, although there may be an increased risk of reoperation in TV repair.[3](#jah35024-bib-0003){ref-type="ref"}, [9](#jah35024-bib-0009){ref-type="ref"}, [14](#jah35024-bib-0014){ref-type="ref"}, [15](#jah35024-bib-0015){ref-type="ref"} A recent landmark study conducted by Zack et al[5](#jah35024-bib-0005){ref-type="ref"} also reported higher in‐hospital mortality in TV replacement compared with TV repair in isolated tricuspid TV surgery.

Because TV surgery is much less often performed compared with mitral and aortic valve surgery, existing studies comparing the outcomes of TV repair and replacement have mostly been conducted in a single center limited by a small number of patients, heterogeneous patient profiles in terms of concomitant underlying medical and surgical conditions, and lack of late outcome results other than mortality. Larger‐scale studies have been conducted in Western countries with limited data from the Asian population.[1](#jah35024-bib-0001){ref-type="ref"}, [3](#jah35024-bib-0003){ref-type="ref"}, [6](#jah35024-bib-0006){ref-type="ref"}, [7](#jah35024-bib-0007){ref-type="ref"} Therefore, we used a national cohort of Taiwanese patients who underwent TV surgery to compare the long‐term outcomes of TV repair and replacement in both isolated and concomitant surgery to address the aforementioned knowledge gap. Considering the increasing interest in transcatheter TV intervention,[16](#jah35024-bib-0016){ref-type="ref"} the outcomes in our study might help highlight key implications to develop a novel intervention for severely ill patients with TR.

Methods {#jah35024-sec-0010}
=======

Data Source {#jah35024-sec-0011}
-----------

The data that support the findings of this study are available from the corresponding author on reasonable request.

This study was designed as a retrospective cohort design using data obtained from the Taiwan National Health Insurance Research Database (NHIRD) from January 1, 2000, to December 31, 2013. The NHIRD entails data derived from Taiwan\'s National Health Insurance (NHI) program, a universal compulsory health insurance system offering comprehensive medical coverage to 99% of the total population of 24 million.[9](#jah35024-bib-0009){ref-type="ref"}, [17](#jah35024-bib-0017){ref-type="ref"}, [18](#jah35024-bib-0018){ref-type="ref"}, [19](#jah35024-bib-0019){ref-type="ref"} The NHI program enables the continuous tracking of all claims from each individual, given that it includes a consistent data encryption process. High‐quality comprehensive medical services are offered at a low cost, and major surgical procedures are also financed by the program. Because of the aforementioned advantages, a nearly complete long‐term follow‐up of patients with minimal dropout is thus possible. This study was exempt from a full review by the Institutional Review Board of Chang Gung Memorial Hospital as all data in the NHIRD are deidentified and anonymized.

Study Population {#jah35024-sec-0012}
----------------

Using the *International Classification of Diseases, Ninth Revision, Clinical Modification* (*ICD‐9‐CM*) procedure codes, adult patients (aged \>18 years) who underwent TV surgery were identified (Figure [1](#jah35024-fig-0001){ref-type="fig"}). Patients were excluded if they had any diagnosis of congenital heart disease, infective endocarditis, cardiac transplant, redo valvular surgery, or TV repair (*ICD‐9‐CM* procedure code: 35.14) and replacement (*ICD‐9‐CM* procedure codes: 35.27, 35.28) at the time of admission, as these represent an essentially different group of patient population. Patients who first received TV surgery were further divided into an isolated and concomitant group based on whether concomitant aortic, mitral, or pulmonary valve surgery was performed simultaneously using *ICD‐9‐CM* procedure codes.

![**A**, Flowchart of the study patient inclusion. **B**, Valve surgery volume and proportion of tricuspid surgery from 2000 to 2013 in Taiwan.\
TV indicates tricuspid valve; and y/o, years old.](JAH3-9-e015637-g001){#jah35024-fig-0001}

Covariates and Outcomes {#jah35024-sec-0013}
-----------------------

Demographic information included age, sex, and level of hospital where the patients received surgery. The comorbidities were identified using any inpatient diagnosis before the index date, which could be traced up to 1997. Perioperative complications during the index admission were identified by either *ICD‐9‐CM* diagnostic codes or Taiwan NHI reimbursement codes. Details of the *ICD‐9‐CM* codes are listed in Table [S1](#jah35024-sup-0001){ref-type="supplementary-material"}. The late outcomes were all‐cause mortality, composite outcome (redo surgery, heart failure, pacemaker, and major bleeding), and readmission attributable to any cause. Mortality was defined by withdrawal from the NHI program.[20](#jah35024-bib-0020){ref-type="ref"} Redo surgery and pacemaker installation information was extracted from Taiwan NHI reimbursement codes. The definition of major bleeding has been widely reported in previous NHIRD studies,[21](#jah35024-bib-0021){ref-type="ref"} which is defined as a primary diagnosis of intracranial hemorrhage or urogenital, gastrointestinal, or other bleeding during a hospitalization or an emergency department visit. The diagnostic codes of heart failure have proved to have high accuracy, which demonstrated 99% sensitivity in agreement of diagnosis among hospital mortality cases in the NHIRD compared with the electronic medical records.[22](#jah35024-bib-0022){ref-type="ref"} All patients were followed up from the index admission date until December 31, 2013, or the date of death.

Statistical Analysis {#jah35024-sec-0014}
--------------------

To reduce confounding when comparing outcomes between TV repair and replacement surgery, we used the inverse probability of treatment weighting based on the propensity scores. To calculate propensity scores (ie, stratification, matching, statistical control, and weighting), the inverse probability of treatment weighting was recently considered the most efficient in reducing confounding and has demonstrated higher statistical power compared with matching.[23](#jah35024-bib-0023){ref-type="ref"} The propensity score was estimated using a logistic regression model in which treatment assignment was regressed on the selected covariates listed in Table [1](#jah35024-tbl-0001){ref-type="table"}, except for the follow‐up year, which was replaced with the year of index admission. To prevent the effect of extreme value of the estimated propensity score, we used a stabilized weight to mitigate the influence of outliers.[24](#jah35024-bib-0024){ref-type="ref"} The quality of weighting was verified using the absolute value of standardized difference between the groups after weighting, where a value \<0.1 was considered negligible difference, and a value \<0.2 was considered a small effect size of the group difference. In this study, the analysis was stratified by isolated versus concomitant surgeries; therefore, the propensity scores were generated separately for these 2 different cohorts.

###### 

Clinical and Surgical Characteristics of Patients With Isolated TV Surgery

  Variable                                Data Before IPTW[a](#jah35024-note-0005){ref-type="fn"}   Data After IPTW[b](#jah35024-note-0006){ref-type="fn"}                                                 
  --------------------------------------- --------------------------------------------------------- -------------------------------------------------------- ------------ -------- ----------- ----------- --------
  Age, y                                  54.7±16.2                                                 55.6±16.4                                                53.5±15.9    0.128    55.2±16.3   56.1±15.6   −0.055
  Age group, y                                                                                                                                                                                             
  \<40                                    68 (20.4)                                                 37 (18.9)                                                31 (22.6)    −0.093   20.2        18.7        0.037
  40--59                                  131 (39.3)                                                74 (37.8)                                                57 (41.6)    −0.079   37.6        35.1        0.051
  60--79                                  120 (36.0)                                                77 (39.3)                                                43 (31.4)    0.166    39.0        43.1        −0.083
  ≥80                                     14 (4.2)                                                  8 (4.1)                                                  6 (4.4)      −0.015   3.3         3.1         0.010
  Women                                   160 (48.0)                                                99 (50.5)                                                61 (44.5)    0.120    46.2        41.3        0.099
  Medical comorbidities                                                                                                                                                                                    
  Diabetes mellitus                       59 (17.7)                                                 36 (18.4)                                                23 (16.8)    0.041    21.0        19.1        0.046
  Hypertension                            120 (36.0)                                                76 (38.8)                                                44 (32.1)    0.140    36.4        35.9        0.009
  Heart failure                           124 (37.2)                                                70 (35.7)                                                54 (39.4)    −0.076   39.7        37.2        0.052
  Myocardial infarction                   21 (6.3)                                                  15 (7.7)                                                 6 (4.4)      0.138    6.6         8.6         −0.077
  Stroke                                  23 (6.9)                                                  11 (5.6)                                                 12 (8.8)     −0.122   6.0         5.8         0.005
  History of PPM/ICD                      10 (3.0)                                                  3 (1.5)                                                  7 (5.1)      −0.201   1.8         2.6         −0.053
  Peripheral arterial disease             7 (2.1)                                                   4 (2.0)                                                  3 (2.2)      −0.010   1.5         1.5         0.001
  Atrial fibrillation                     105 (31.5)                                                48 (24.5)                                                57 (41.6)    −0.370   31.7        30.5        0.026
  Pulmonary hypertension                  54 (16.2)                                                 38 (19.4)                                                16 (11.7)    0.214    15.8        12.5        0.096
  Chronic kidney disease                  43 (12.9)                                                 23 (11.7)                                                20 (14.6)    −0.085   12.6        13.7        −0.033
  Dialysis                                7 (2.1)                                                   4 (2.0)                                                  3 (2.2)      −0.010   1.8         1.5         0.024
  Chronic obstructive pulmonary disease   32 (9.6)                                                  21 (10.7)                                                11 (8.0)     0.092    10.3        10.0        0.010
  Liver cirrhosis                         25 (7.5)                                                  7 (3.6)                                                  18 (13.1)    −0.351   7.3         7.2         0.004
  Coagulopathy                            17 (5.1)                                                  5 (2.6)                                                  12 (8.8)     −0.271   4.2         4.5         −0.016
  Gastrointestinal bleeding               57 (17.1)                                                 27 (13.8)                                                30 (21.9)    −0.213   17.3        17.7        −0.011
  Major bleeding                          28 (8.4)                                                  12 (6.1)                                                 16 (11.7)    −0.196   6.8         7.2         −0.016
  Charlson score                          2.2±2.3                                                   2.2±2.4                                                  2.2±2.2      −0.011   2.3±2.5     2.4±2.7     −0.038
  Hospital level                                                                                                                                                                                           
  Medical center (teaching hospital)      275 (82.6)                                                166 (84.7)                                               109 (79.6)   0.134    83.4        83.4        0.001
  Regional/district hospital              58 (17.4)                                                 30 (15.3)                                                28 (20.4)    −0.134   16.6        16.6        −0.001
  Concomitant CABG                        46 (13.8)                                                 38 (19.4)                                                8 (5.8)      0.417    14.0        16.9        −0.080
  Maze                                    65 (19.5)                                                 49 (25.0)                                                16 (11.7)    0.349    19.5        22.9        −0.083
  Follow‐up time, y                       4.4±3.8                                                   4.7±3.8                                                  4.0±3.8      0.199    4.8±4.0     4.2±4.3     0.129

CABG indicates coronary artery bypass graft; ICD, intracardiac defibrillator; IPTW, inverse probability of treatment weighting; PPM, permanent pacemaker; STD, standardized difference; and TV, tricuspid valve.

Values are given as number (percentage) or mean±SD.

Values are given as percentage or mean±SD.

The trend of performing TV surgeries among all the valve surgeries across years was tested using the Cochran‐Armitage trend test. Likewise, the changes in the proportion of TV repair surgery received (of all TV surgical procedures) or in the proportion of in‐hospital deaths in either groups across the study periods (2000--2004, 2005--2009, and 2010--2013) were also tested through the Cochran‐Armitage trend test. The operation‐related complications and outcomes during the admission in the repair and replacement groups were compared using a logistic regression model for binary outcomes or a linear regression model for continuous outcomes. For the late outcomes after discharge, the mortality rates between groups were compared using a Cox proportional hazard model. The incidences of nonfatal outcomes between groups were compared using the Fine and Gray subdistribution hazard model that considers death as a competing risk. The study group (repair versus replacement) was the only explanatory variable in the analysis of isolated TV surgery, whereas the age and coronary artery bypass grafting were additionally adjusted in the analysis of concomitant TV surgery to account for the possibility of residual confounding.

The assumption of proportional hazards in either the Cox or the Fine and Gray models was tested using an interaction term of a time‐varying covariate by study group (repair versus replacement). The results showed that the *P* values of all‐cause mortality, composite outcome, and all‐cause readmission were 0.044, 0.929, and 0.142, respectively, in the isolated TV surgeries. For the concomitant TV surgeries, the *P* values of all‐cause mortality, composite outcome, and all‐cause readmission were 0.001, 0.590, and 0.130, respectively.

To investigate the risk factors of in‐hospital death, univariate analyses (*t* test or the χ^2^ test) were performed, and variables with *P*\<0.2 were further introduced into the multivariable logistic regression analysis with backward selection. Finally, a falsification analysis was conducted to detect residual confounding between the groups after weighting.[25](#jah35024-bib-0025){ref-type="ref"} We selected 2 irrelevant outcomes of relatively high incidence (namely, incident fracture and newly diagnosed malignancy) as the falsification end points. A 2‐sided *P*\<0.05 was considered statistically significant, and no adjustment of multiple testing (multiplicity) was made to avoid low statistical power in this study. All statistical analyses were performed using SAS, version 9.4 (SAS Institute, Cary, NC).

Results {#jah35024-sec-0015}
=======

Epidemiological Characteristics of TV Surgery in Taiwan {#jah35024-sec-0016}
-------------------------------------------------------

Between January 2000 and December 2013, a total of 2644 patients who received TV surgery for the first time were included in our study, of which 333 (12.6%) underwent isolated TV surgery and 2311 (87.4%) underwent concomitant TV surgery. TV surgeries share \<9% of overall cardiac valve surgery volume in Taiwan. The trend of performing TV surgeries among all the valve surgeries increased from 4.9% in 2000 to 8.1% in 2013 (Figure [1](#jah35024-fig-0001){ref-type="fig"}B). The in‐hospital mortality rates were 8.7% in isolated TV surgery and 8.6% in concomitant TV surgery (data not presented). The number of TV operations across the study periods remained relatively constant (Figure [2](#jah35024-fig-0002){ref-type="fig"}A).

![Number of tricuspid valve (TV) operations (**A**), proportion of TV repair operations received (of all TV operations), or proportion of in‐hospital deaths within the repair and replacement groups in patients with isolated surgery (**B**) and concomitant TV surgery (**C**) across the study periods.\
The error bar represents the 95% CI of the proportion.](JAH3-9-e015637-g002){#jah35024-fig-0002}

Of the 333 patients who underwent isolated TV surgery, 196 (58.9%) underwent TV repair and 137 (41.1%) underwent TV replacement. The proportion of patients who received TV repair did not significantly change across the study periods (*P* trend=0.645). The in‐hospital mortality rate was not significantly changed across the study periods in both the repair and replacement groups (Figure [2](#jah35024-fig-0002){ref-type="fig"}B). In general, the in‐hospital mortality rate was lower in the repair group than in the replacement group (6.6% \[13/196\] versus 11.7% \[16/137\]).

Of the remaining 2311 patients who underwent concomitant TV surgery, 1974 (85.4%) underwent TV repair and 337 (14.6%) underwent TV replacement. Similarly, the proportion of patients who received TV repair remained unchanged across the study periods (*P* trend=0.129). The in‐hospital mortality rate was also stable across the study periods in both the repair and the replacement groups (Figure [2](#jah35024-fig-0002){ref-type="fig"}C). As illustrated in the figure, the in‐hospital mortality rate was much lower in the repair group than in the replacement group (7.1% \[141/1974\] versus 17.2% \[58/337\]).

Baseline Characteristics of the Study Population {#jah35024-sec-0017}
------------------------------------------------

For the isolated TV surgery group, the mean age was 55.6 years (SD, 16.4 years); and the mean age was 53.5 years (SD, 15.9 years) in the repair and replacement group. Most operations (82.6%) were performed in medical centers. There were substantial differences in terms of the characteristics before weighting. However, the group differences in characteristics were negligible after weighting, with all the absolute values of standardized difference \<0.1 (Table [1](#jah35024-tbl-0001){ref-type="table"}). For the concomitant TV surgery group, the mean age was 60.8 years (SD, 13.3 years); and the mean age was 60.3 years (SD, 14.2 years) in the repair and replacement group. Similarly, most operations (85.9%) were performed in medical centers. Most of the characteristics were well balanced between the 2 groups after weighting, except for age and coronary artery bypass grafting, which exhibited a small effect size of group difference (standardized difference range, 0.1--0.2) (Table [2](#jah35024-tbl-0002){ref-type="table"}).

###### 

Clinical and Surgical Characteristics of Patients With Concomitant TV Surgery

  Variable                                Data Before IPTW[a](#jah35024-note-0008){ref-type="fn"}   Data After IPTW[b](#jah35024-note-0009){ref-type="fn"}                                                 
  --------------------------------------- --------------------------------------------------------- -------------------------------------------------------- ------------ -------- ----------- ----------- --------
  Age, y                                  60.7±13.4                                                 60.8±13.3                                                60.3±14.2    0.034    60.7±13.3   62.9±14.0   −0.157
  Age group, y                                                                                                                                                                                             
  \<40                                    165 (7.1)                                                 139 (7.0)                                                26 (7.7)     −0.026   7.0         4.8         0.096
  40--59                                  874 (37.8)                                                740 (37.5)                                               134 (39.8)   −0.047   37.8        34.7        0.065
  60--79                                  1146 (49.6)                                               994 (50.4)                                               152 (45.1)   0.105    49.6        50.8        −0.025
  ≥80                                     126 (5.5)                                                 101 (5.1)                                                25 (7.4)     −0.095   5.6         9.7         −0.155
  Women                                   1236 (53.5)                                               1044 (52.9)                                              192 (57.0)   −0.082   53.4        56.0        −0.053
  Medical comorbidities                                                                                                                                                                                    
  Diabetes mellitus                       455 (19.7)                                                391 (19.8)                                               64 (19.0)    0.021    19.8        18.5        0.032
  Hypertension                            883 (38.2)                                                768 (38.9)                                               115 (34.1)   0.099    38.3        37.4        0.018
  Heart failure                           1170 (50.6)                                               990 (50.2)                                               180 (53.4)   −0.065   50.7        46.8        0.078
  Myocardial infarction                   141 (6.1)                                                 127 (6.4)                                                14 (4.2)     0.102    6.0         4.6         0.063
  Stroke                                  257 (11.1)                                                216 (10.9)                                               41 (12.2)    −0.038   11.1        13.3        −0.068
  History of PPM/ICD                      53 (2.3)                                                  39 (2.0)                                                 14 (4.2)     −0.127   2.3         2.7         −0.025
  Peripheral arterial disease             55 (2.4)                                                  44 (2.2)                                                 11 (3.3)     −0.063   2.3         1.8         0.035
  Atrial fibrillation                     1325 (57.3)                                               1119 (56.7)                                              206 (61.1)   −0.090   57.3        56.2        0.021
  Pulmonary hypertension                  491 (21.2)                                                424 (21.5)                                               67 (19.9)    0.039    21.2        18.4        0.071
  Chronic kidney disease                  274 (11.9)                                                227 (11.5)                                               47 (13.9)    −0.073   11.9        12.4        −0.015
  Dialysis                                60 (2.6)                                                  51 (2.6)                                                 9 (2.7)      −0.005   2.6         1.8         0.054
  Chronic obstructive pulmonary disease   201 (8.7)                                                 175 (8.9)                                                26 (7.7)     0.042    8.8         9.2         −0.016
  Liver cirrhosis                         85 (3.7)                                                  58 (2.9)                                                 27 (8.0)     −0.224   3.7         4.3         −0.031
  Coagulopathy                            91 (3.9)                                                  70 (3.5)                                                 21 (6.2)     −0.125   4.0         3.9         0.003
  Gastrointestinal bleeding               419 (18.1)                                                361 (18.3)                                               58 (17.2)    0.028    18.2        19.2        −0.025
  Major bleeding                          180 (7.8)                                                 149 (7.5)                                                31 (9.2)     −0.060   7.8         8.7         −0.032
  Charlson score                          2.2±2.0                                                   2.2±1.9                                                  2.4±2.2      −0.108   2.2±2.0     2.2±2.0     0.023
  Hospital level                                                                                                                                                                                           
  Medical center (teaching hospital)      1985 (85.9)                                               1725 (87.4)                                              260 (77.2)   0.270    85.8        87.0        −0.033
  Regional/district hospital              326 (14.1)                                                249 (12.6)                                               77 (22.8)    −0.270   14.2        13.0        0.033
  Concomitant CABG                        212 (9.2)                                                 184 (9.3)                                                28 (8.3)     0.036    9.0         5.7         0.129
  Maze                                    405 (17.5)                                                369 (18.7)                                               36 (10.7)    0.228    17.5        16.7        0.022
  Concomitant surgery type                                                                                                                                                                                 
  AVR (mechanical)                        429 (18.6)                                                364 (18.4)                                               65 (19.3)    −0.022   18.6        20.6        −0.050
  AVR (tissue)                            159 (6.9)                                                 136 (6.9)                                                23 (6.8)     0.003    6.9         7.3         −0.019
  MV repair                               672 (29.1)                                                652 (33.0)                                               20 (5.9)     0.728    29.1        27.4        0.037
  MV replacement (mechanical)             1123 (48.6)                                               903 (45.7)                                               220 (65.3)   −0.401   48.6        53.3        −0.094
  MV replacement (tissue)                 392 (17.0)                                                322 (16.3)                                               70 (20.8)    −0.115   17.0        19.2        −0.057
  Follow‐up time, y                       4.9±4.1                                                   4.9±4.0                                                  4.3±4.2      0.147    5.0±4.1     4.1±3.9     0.238

AVR indicates Aortic valve replacement; CABG, coronary artery bypass graft; ICD, intracardiac defibrillator; IPTW, inverse probability of treatment weighting; MV: Mitral valve; PPM, permanent pacemaker; STD, standardized difference; and TV, tricuspid valve.

Values are given as number (percentage) or mean±SD.

Values are given as percentage or mean±SD.

In addition, we further compared the baseline characteristics of patients undergoing valve replacement, and the details are shown in Table [S2](#jah35024-sup-0001){ref-type="supplementary-material"}.

Operation‐Related Complications and Outcomes {#jah35024-sec-0018}
--------------------------------------------

In patients who underwent isolated TV surgery, the in‐hospital mortality rate was significantly lower in the repair than in the replacement group (5.8% versus 13.8%; odds ratio, 0.39; 95% CI, 0.18--0.85). Other perioperative outcomes favored the repair group, including massive blood transfusion, sepsis, in‐hospital stay, prolonged hospital stay \>28 days, and hospital cost (Table [3](#jah35024-tbl-0003){ref-type="table"}). Similarly, the in‐hospital mortality rate of patients who underwent concomitant TV surgery was significantly lower in the repair than in the replacement groups (7.3% versus 16.2%; odds ratio, 0.41; 95% CI, 0.31--0.55). With the exception of sepsis, ischemic stroke, and pacemaker installation, the other perioperative outcomes favored the repair group (Table [4](#jah35024-tbl-0004){ref-type="table"}).

###### 

Operation‐Related Complications and Outcomes of Isolated TV Surgery

  Variable                                                           Data Before IPTW[a](#jah35024-note-0011){ref-type="fn"}   Data After IPTW[b](#jah35024-note-0012){ref-type="fn"}                                                             
  ------------------------------------------------------------------ --------------------------------------------------------- -------------------------------------------------------- ----------- ----------- ----------- --------------------- ---------
  Binary outcome                                                                                                                                                                                                                                  
  In‐hospital mortality                                              29 (8.7)                                                  13 (6.6)                                                 16 (11.7)   5.8         13.8        0.39 (0.18, 0.85)     0.018
  New‐onset stroke                                                   10 (3.0)                                                  5 (2.6)                                                  5 (3.6)     2.0         5.0         0.39 (0.11, 1.43)     0.156
  New‐onset ischemic stroke                                          7 (2.1)                                                   3 (1.5)                                                  4 (2.9)     1.1         4.6         0.23 (0.05, 1.18)     0.079
  New‐onset hemorrhagic stroke                                       4 (1.2)                                                   2 (1.0)                                                  2 (1.5)     0.9         0.7         1.28 (0.12, 14.29)    0.839
  Cardiogenic shock requiring MCS                                    14 (4.2)                                                  9 (4.6)                                                  5 (3.6)     4.8         3.9         1.26 (0.44, 3.64)     0.667
  Reexploration for bleeding                                         15 (4.5)                                                  7 (3.6)                                                  8 (5.8)     4.7         5.7         0.80 (0.30, 2.13)     0.661
  Massive blood transfusion[c](#jah35024-note-0013){ref-type="fn"}   60 (18.0)                                                 21 (10.7)                                                39 (28.5)   12.3        30.0        0.33 (0.18, 0.58)     \<0.001
  De novo dialysis                                                   40 (12.0)                                                 20 (10.2)                                                20 (14.6)   9.7         15.4        0.59 (0.30, 1.14)     0.115
  Sepsis                                                             21 (6.3)                                                  6 (3.1)                                                  15 (10.9)   2.7         12.8        0.19 (0.07, 0.54)     0.002
  Pacemaker                                                          14 (4.2)                                                  3 (1.5)                                                  11 (8.0)    2.8         5.8         0.46 (0.15, 1.43)     0.177
  Deep wound infection                                               7 (2.1)                                                   4 (2.0)                                                  3 (2.2)     1.9         1.4         1.40 (0.25, 7.68)     0.702
  Prolonged hospital stays \>28 d                                    119 (35.7)                                                50 (25.5)                                                69 (50.4)   27.3        49.0        0.39 (0.25, 0.62)     \<0.001
  Continuous parameter                                                                                                                                                                                                                            
  ICU duration, d                                                    9.9±14.5                                                  8.3±11.6                                                 12.3±17.6   8.8±11.6    12.0±16.5   −3.23 (−6.98, 0.52)   0.091
  In‐hospital stay, d                                                31.3±28.3                                                 25.8±21.8                                                39.1±34.3   27.5±25.0   36.8±32.2   −9.3 (−17.4, −1.1)    0.027
  In‐hospital cost, NTD×10^4^                                        54.6±42.8                                                 47.7±35.3                                                64.5±50.1   49.1±37.5   64.0±47.7   −14.9 (−26.8, −3.0)   0.014

B indicates regression coefficient; ICU, intensive care unit; IPTW, inverse probability of treatment weighting; MCS, mechanical circulatory support; NTD, New Taiwan Dollars; OR, odds ratio; TV, and tricuspid valve.

Values are given as number (percentage) or mean±SD.

Values are given as percentage or mean±SD.

Packed red blood cells \>10 U.

###### 

Operation‐Related Complications and Outcomes of Concomitant TV Surgery

  Variable                                                           Data Before IPTW[a](#jah35024-note-0015){ref-type="fn"}   Data After IPTW[b](#jah35024-note-0016){ref-type="fn"}                                                               
  ------------------------------------------------------------------ --------------------------------------------------------- -------------------------------------------------------- ------------ ----------- ----------- ---------------------- ---------
  Binary outcome                                                                                                                                                                                                                                    
  In‐hospital mortality                                              199 (8.6)                                                 141 (7.1)                                                58 (17.2)    7.3         16.2        0.41 (0.31, 0.55)      \<0.001
  New‐onset stroke                                                   54 (2.3)                                                  42 (2.1)                                                 12 (3.6)     2.2         4.3         0.48 (0.30, 0.79)      0.004
  New‐onset ischemic stroke                                          42 (1.8)                                                  34 (1.7)                                                 8 (2.4)      1.8         2.1         0.82 (0.45, 1.49)      0.507
  New‐onset hemorrhagic stroke                                       13 (0.6)                                                  9 (0.5)                                                  4 (1.2)      0.5         2.2         0.20 (0.08, 0.50)      0.001
  Cardiogenic shock requiring MCS                                    53 (2.3)                                                  37 (1.9)                                                 16 (4.7)     1.9         6.8         0.26 (0.16, 0.42)      \<0.001
  Reexploration for bleeding                                         86 (3.7)                                                  67 (3.4)                                                 19 (5.6)     3.5         5.8         0.62 (0.41, 0.93)      0.020
  Massive blood transfusion[d](#jah35024-note-0018){ref-type="fn"}   359 (15.5)                                                272 (13.8)                                               87 (25.8)    14.3        24.8        0.50 (0.40, 0.62)      \<0.001
  De novo dialysis                                                   212 (9.2)                                                 158 (8.0)                                                54 (16.0)    8.2         21.1        0.34 (0.27, 0.45)      \<0.001
  Sepsis                                                             67 (2.9)                                                  52 (2.6)                                                 15 (4.5)     2.7         2.7         0.94 (0.56, 1.58)      0.810
  Pacemaker                                                          63 (2.7)                                                  51 (2.6)                                                 12 (3.6)     2.5         4.2         0.63 (0.39, 1.01)      0.055
  Deep wound infection                                               43 (1.9)                                                  31 (1.6)                                                 12 (3.6)     1.6         6.5         0.25 (0.14, 0.42)      \<0.001
  Prolonged hospital stays \>28 d                                    639 (27.7)                                                490 (24.8)                                               149 (44.2)   25.1        47.8        0.37 (0.31, 0.44)      \<0.001
  Continuous parameter                                                                                                                                                                                                                              
  ICU duration, d                                                    8.3±12.4                                                  7.6±11.3                                                 12.8±16.6    7.7±11.6    11.3±14.3   −3.21 (−5.01, −1.40)   \<0.001
  In‐hospital stay, d                                                26.4±22.0                                                 24.9±19.9                                                35.5±30.1    25.1±20.3   34.3±26.3   −8.7 (−12.1, −5.3)     \<0.001
  In‐hospital cost, NTD×10^4^                                        53.1±34.8                                                 50.6±32.0                                                67.8±45.4    50.9±32.6   66.6±42.0   −14.9 (−20.4, −9.4)    \<0.001

B indicates regression coefficient; ICU, intensive care unit; IPTW, inverse probability of treatment weighting; MCS, mechanical circulatory support; NTD, New Taiwan Dollars; OR, odds ratio; and TV, tricuspid valve.

Values are given as number (percentage) or mean±SD.

Values are given as percentage or mean±SD.

Additionally adjusted for age and coronary artery bypass graft.

Packed red blood cells \>10 U.

In addition, we further compared the operation‐related outcomes of mechanical with bioprosthetic valve replacement. The details are shown in Table [S3](#jah35024-sup-0001){ref-type="supplementary-material"}.

Late Outcomes After Discharge {#jah35024-sec-0019}
-----------------------------

In patients who underwent isolated TV surgery, a trend appeared toward a lower all‐cause mortality rate in the repair group (35.7% versus 48.3%; hazard ratio \[HR\], 0.66; 95% CI, 0.42--1.04), although not significant (*P*=0.072; Figure [3](#jah35024-fig-0003){ref-type="fig"}A). The repair group had lower incidences of composite outcome (22.5% versus 41.5%; subdistribution HR \[SHR\], 0.55; 95% CI, 0.35--0.89) and readmission (57.7% versus 70.1%; SHR, 0.64; 95% CI, 0.46--0.91) compared with the replacement group (Figure [3](#jah35024-fig-0003){ref-type="fig"}B and [3](#jah35024-fig-0003){ref-type="fig"}C).

![Unadjusted cumulative event rate of all‐cause mortality in patients who underwent isolated (**A**) and concomitant tricuspid valve (TV) surgery (**D**); cumulative incidence function of composite outcome in patients who underwent isolated (**B**) and concomitant TV surgery (**E**); and cumulative incidence function of admission in patients who underwent isolated (**C**) and concomitant TV surgery (**F**) after inverse probability of treatment weighting.](JAH3-9-e015637-g003){#jah35024-fig-0003}

In patients who underwent concomitant TV surgery, a trend appeared toward a lower all‐cause mortality rate in the repair group (35.4% versus 41.4%; HR, 0.76; 95% CI, 0.59--0.99) (Figure [3](#jah35024-fig-0003){ref-type="fig"}D). The repair group had lower incidences of composite outcome (28.0% versus 39.6%; SHR, 0.63; 95% CI, 0.46--0.86), pacemaker implantation (5.2% versus 14.2%; SHR, 0.37; 95% CI, 0.17--0.81), and readmission (66.1% versus 76.8%; SHR, 0.72; 95% CI, 0.60--0.86) compared with the replacement group (Figure [3](#jah35024-fig-0003){ref-type="fig"}E and [3](#jah35024-fig-0003){ref-type="fig"}F). The detailed data of each outcome being compared are provided in Tables [S4 and S5](#jah35024-sup-0001){ref-type="supplementary-material"}.

In addition, we further compared the late outcomes of mechanical with bioprosthetic valve replacement, and the details are shown in Table [S6](#jah35024-sup-0001){ref-type="supplementary-material"}.

Risk Factors of In‐Hospital Mortality {#jah35024-sec-0020}
-------------------------------------

After introducing the variables with *P*\<0.2 in the univariate analyses (Table [S7](#jah35024-sup-0001){ref-type="supplementary-material"}) into the multivariable analysis with backward selection, the result indicated the following risk factors for patients who underwent isolated TV surgery: male sex, history of diabetes mellitus, myocardial infarction, and major bleeding. For patients who underwent concomitant TV surgery, the result indicated the following risk factors: older age, male sex, history of permanent pacemaker/intracardiac defibrillator, chronic kidney disease, coagulopathy, receiving surgery in nonmedical centers, the presence of concomitant coronary artery bypass grafting, and the absence of concomitant maze (Table [S8](#jah35024-sup-0001){ref-type="supplementary-material"}).

Sensitivity Analysis for Unmeasured Confounding {#jah35024-sec-0021}
-----------------------------------------------

Using 2 irrelevant falsification end points (namely, incident fracture and newly diagnosed malignancy), the results demonstrated that the incidence of both outcomes did not significantly differ in the repair and replacement groups in either the isolated or the concomitant TV surgery groups, which may provide supportive evidence against the existence of unmeasured confounding (Table [S9](#jah35024-sup-0001){ref-type="supplementary-material"}).

Discussion {#jah35024-sec-0022}
==========

The present study demonstrated 3 main findings, as follows: first, the volume and death rate of isolated and concomitant TV repair and replacement surgery remained constant over the 14‐year study period in Taiwan; second, in‐hospital mortality was lower in both the isolated and the concomitant TV repair groups; third, the long‐term outcomes in terms of composite outcome (redo surgery, heart failure, pacemaker, and major bleeding) and readmission attributable to any cause were significantly lower in both the isolated and the concomitant TV repair groups.

Compared with previous editions, the latest European Society of Cardiology and American Heart Association guidelines advocate early intervention in patients with TR. In contrast to the increasing use of TV surgery in the Western countries,[1](#jah35024-bib-0001){ref-type="ref"}, [5](#jah35024-bib-0005){ref-type="ref"} the number of TV surgeries and the TV repair rate in both isolated and concomitant surgery performed in Taiwan remained constant over the 14‐year period. The absence of increase in the use may reflect the reluctance of both surgeons and patients to undergo surgery when medical treatment is available and hence the possible delay referral for surgical evaluation by cardiac surgeons, because of the high perceived mortality of up to 14% in large‐scale studies.[1](#jah35024-bib-0001){ref-type="ref"}, [2](#jah35024-bib-0002){ref-type="ref"}, [3](#jah35024-bib-0003){ref-type="ref"}, [4](#jah35024-bib-0004){ref-type="ref"}, [5](#jah35024-bib-0005){ref-type="ref"}, [6](#jah35024-bib-0006){ref-type="ref"}, [7](#jah35024-bib-0007){ref-type="ref"}, [8](#jah35024-bib-0008){ref-type="ref"}

In accordance with the findings in a study conducted in the United States that repair rate was 41.7% (569/1364) in isolated and 83.8% (6563/7830) in concomitant TV surgery,[1](#jah35024-bib-0001){ref-type="ref"} the present study also demonstrated the proportion of TV repair was lower in isolated TV surgery than that in concomitant surgery (58.9% versus 85.4%, respectively). The choice of TV repair or replacement depends on several factors, such as disease cause, surgical timing, anatomical features of annulus and leaflet, and clinical experience of the surgeon.[26](#jah35024-bib-0026){ref-type="ref"} Although TV repair is a preferred option to prevent complications of tissue and mechanical valve replacement, the lower TV repair rate in isolated surgery may be explained by primary leaflet problems constituting most isolated TV surgery cases that render repair impossible, whereas secondary TR constitutes most concomitant TV surgery cases and repair is often feasible. In addition, there may be a delay in referral to isolated TV surgery because patients remain asymptomatic for a long period of time and by the time they are referred, repair is usually not feasible,[27](#jah35024-bib-0027){ref-type="ref"} which is not the case in concomitant TV surgery.

The overall in‐hospital mortality rates for TV surgery in the present study were 8.7% in isolated TV surgery and 8.6% in concomitant TV surgery. Consistent with large‐scale studies conducted on the basis of the US Nationwide Inpatient Sample database, our study also revealed that repair was superior to replacement in isolated and concomitant TV surgery and a higher mortality in the concomitant group than in the isolated group.[1](#jah35024-bib-0001){ref-type="ref"}, [5](#jah35024-bib-0005){ref-type="ref"}, [6](#jah35024-bib-0006){ref-type="ref"} Regardless of the advancement in surgical techniques, the mortality did not decrease significantly over a 14‐year period. This is probably because of multiple preexisting medical comorbidities in patients with TV diseases, such as atrial fibrillation and heart failure. These patients are usually referred to surgical interventions late with severe right ventricular dysfunction or end‐organ damage, especially in those patients with primary TR for isolated TV surgery.[9](#jah35024-bib-0009){ref-type="ref"} Endovascular intervention has been attempted to improve the mortality in the high‐risk group.[16](#jah35024-bib-0016){ref-type="ref"}

A meta‐analysis by Choi and colleagues, pooling 17 retrospective studies comparing TV repair and TV replacement in patients with TR for all‐cause mortality as the primary outcome, demonstrated that replacement was associated with higher all‐cause mortality compared with repair (HR, 1.59; 95% CI, 1.26--2.00).[28](#jah35024-bib-0028){ref-type="ref"} A recent study conducted by Saran et al[29](#jah35024-bib-0029){ref-type="ref"} on long‐term outcomes demonstrated a better long‐term survival in repair compared with replacement. The aforementioned studies may be subject to the limitations of pooling all types of TV surgery for analysis or not imposing strict exclusion criteria to reduce the heterogeneous nature of the study population. We therefore set strict exclusion criteria in the study groups and used a 2‐arm design to separate patients into isolated and concomitant groups to overcome these problems. Although we only demonstrated a significant difference in all‐cause mortality between repair and replacement in concomitant but not in isolated TV surgery, the composite outcome and readmission attributable to any cause were significantly superior in TV repair than in TV replacement in both isolated and concomitant TV surgery. The composite outcome rather than the individual outcome is more translational in the clinical context, considering multiple adverse events can occur in any individual patient.

The demerit of replacement is that when a rigid prosthetic valve is placed in a deformable, low‐pressure cavity, it could lead to progressive right ventricular dysfunction in the long run.[8](#jah35024-bib-0008){ref-type="ref"} Mechanical prosthetic valves are also associated with the risk of thrombosis and anticoagulant use.[12](#jah35024-bib-0012){ref-type="ref"} Although tricuspid repair was reported in several previous studies as associated with a higher recurrence of severe TR, which warrants reoperation,[4](#jah35024-bib-0004){ref-type="ref"}, [9](#jah35024-bib-0009){ref-type="ref"}, [14](#jah35024-bib-0014){ref-type="ref"} overall, other studies, together with ours, have favored TV repair because of its superior long‐term outcomes.[28](#jah35024-bib-0028){ref-type="ref"}, [29](#jah35024-bib-0029){ref-type="ref"}, [30](#jah35024-bib-0030){ref-type="ref"} Our study did not intend to differentiate the severity of tricuspid disease in the study population. A point to note is that the benefits of TV repair observed may reflect the greater disease burden in patients who underwent replacement, who may not survive well even after surgical correction, despite the improvement in perioperative and postoperative care.

Study Strengths {#jah35024-sec-0023}
---------------

The main strength of this study is the application of a 2‐arm design separating patients into isolated and concomitant groups for the analysis of long‐term outcomes. This study also benefits from a relatively unselected population of a national cohort with not only early but also multiple late outcome parameters capturing both isolated and concomitant TV surgery. Taiwan\'s NHI program covers nearly all residents in Taiwan, given that it is a compulsory national insurance scheme, unlike the insurance system in other regions, which could possibly reject certain patients receiving surgical treatment. Our study can also overcome the pitfalls of only early outcome, single‐center design with a small number of patients, and inability to demonstrate the wide variety of complications that can arise later on. We evaluated multiple late outcome parameters with a mean follow‐up of 4.9 years.

Limitations {#jah35024-sec-0024}
-----------

This study is subject to the inherent limitations of an administrative database, such as the NHIRD. Detailed clinical and surgical data, including laboratory data, left ventricular ejection fraction, right ventricular function, severity of TR, heart failure symptoms, pulmonary arterial pressure, surgical timing and indication, TV repair technique, and prosthesis detail of TV replacement, are not available. This constituted the major limitation of our study (ie, the inability to adjust for the severity of tricuspid disease). The results on the superiority of repair observed may be attributable to residual confounding of unknown or unmeasured confounders that could not be excluded, although inverse probability of treatment weighting based on the propensity scores was used when comparing the outcomes. Because of the retrospective nature of this administrative database study, we can only establish association but not causal relationship of TV repair and superior results. Despite the aforementioned, the accuracy of the NHIRD in cardiac surgery or cardiovascular diseases has been validated in previous studies.[31](#jah35024-bib-0031){ref-type="ref"} Another problem with the NHIRD is that it may be prone to misclassification and coding errors, because it classifies patients and operative procedures on the basis of *ICD‐9‐CM* codes. However, the NHI program strictly regulates examination, medication, and surgery reimbursements. Comprehensive medical records review the entailing laboratory data and imaging study safeguard examination or interventions granted to patients with clinical indications, thus limiting potential bias. In addition, the NHIRD guarantees limited missing data with nearly complete follow‐up by means of linkage to the national mortality records. At last, the lack of correction for multiple testing may preserve some statistical power but increases the risk of type I error in this study.

Conclusions {#jah35024-sec-0025}
===========

Although TV surgeries share \<9% of overall cardiac valve surgery volume in Taiwan, they carry a high mortality rate and have not improved over the past years. Both TV repair and TV replacement are associated with high in‐hospital and all‐cause mortality in both isolated and concomitant TV surgery. However, TV repair is associated with superior short‐ and long‐term (composite) outcomes in both isolated and concomitant TV surgery. Our findings suggest TV repair may be strongly considered first; however, further prospective clinical trials are warranted.
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